Insulet Return on Investment 2010-2025 | PODD

Current and historical return on investment (ROI) values for Insulet (PODD) over the last 10 years.
Insulet ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2025-03-31 $0.34B $2.94B 13.26%
2024-12-31 $0.31B $2.51B 13.02%
2024-09-30 $0.31B $2.47B 13.47%
2024-06-30 $0.27B $2.36B 12.72%
2024-03-31 $0.25B $2.15B 12.22%
2023-12-31 $0.22B $2.10B 11.18%
2023-09-30 $0.14B $1.98B 7.24%
2023-06-30 $0.09B $1.92B 4.61%
2023-03-31 $0.03B $1.87B 1.53%
2022-12-31 $0.04B $1.85B 2.08%
2022-09-30 $0.06B $1.81B 3.53%
2022-06-30 $0.10B $1.81B 5.27%
2022-03-31 $0.15B $1.84B 8.35%
2021-12-31 $0.13B $1.81B 7.31%
2021-09-30 $0.07B $1.76B 4.10%
2021-06-30 $0.06B $1.69B 3.63%
2021-03-31 $0.06B $1.64B 3.89%
2020-12-31 $0.05B $1.65B 3.79%
2020-09-30 $0.08B $1.52B 6.35%
2020-06-30 $0.07B $1.47B 6.27%
2020-03-31 $0.05B $0.96B 5.21%
2019-12-31 $0.05B $0.96B 5.29%
2019-09-30 $0.05B $1.14B 5.30%
2019-06-30 $0.04B $0.86B 4.65%
2019-03-31 $0.03B $0.82B 4.30%
2018-09-30 $0.01B $0.78B 1.33%
2018-06-30 $0.01B $0.76B 0.76%
2017-12-31 $-0.01B $0.73B -1.44%
2017-09-30 $-0.01B $0.42B -2.47%
2017-06-30 $-0.01B $0.41B -2.51%
2017-03-31 $-0.01B $0.40B -2.30%
2016-12-31 $-0.01B $0.40B -3.69%
2016-09-30 $-0.02B $0.39B -7.98%
2016-06-30 $-0.04B $0.20B -17.64%
2016-03-31 $-0.05B $0.20B -22.70%
2015-12-31 $-0.05B $0.21B -20.94%
2015-09-30 $-0.04B $0.23B -14.29%
2015-06-30 $-0.02B $0.25B -9.19%
2015-03-31 $-0.01B $0.26B -5.55%
2014-12-31 $-0.01B $0.25B -3.61%
2014-09-30 $-0.01B $0.25B -4.04%
2014-06-30 $-0.02B $0.25B -9.81%
2014-03-31 $-0.03B $0.24B -10.25%
2013-12-31 $-0.03B $0.24B -11.97%
2013-09-30 $-0.04B $0.24B -16.04%
2013-06-30 $-0.03B $0.25B -13.23%
2013-03-31 $-0.03B $0.24B -17.87%
2012-12-31 $-0.04B $0.15B -22.54%
2012-09-30 $-0.04B $0.15B -24.05%
2012-06-30 $-0.04B $0.16B -23.89%
2012-03-31 $-0.05B $0.18B -24.74%
2011-12-31 $-0.04B $0.19B -24.23%
2011-09-30 $-0.04B $0.19B -25.65%
2011-06-30 $-0.04B $0.20B -26.98%
2011-03-31 $-0.04B $0.13B -26.37%
2010-12-31 $-0.04B $0.14B -28.94%
2010-09-30 $-0.04B $0.13B -29.60%
2010-06-30 $-0.05B $0.14B -35.25%
2010-03-31 $-0.05B $0.14B -44.64%
2009-12-31 $-0.06B $0.15B -54.72%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $21.652B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.851B 27.88
Boston Scientific (BSX) United States $151.436B 37.91
Stryker (SYK) United States $144.721B 30.26
EssilorLuxottica (ESLOY) France $129.653B 0.00
Medtronic (MDT) Ireland $110.247B 15.63
Lonza Group Ag (LZAGY) Switzerland $50.183B 0.00
Haleon (HLN) United Kingdom $47.171B 26.90
ResMed (RMD) United States $37.320B 28.03
Agilent Technologies (A) United States $32.988B 21.51
GE HealthCare Technologies (GEHC) United States $32.583B 15.47
Terumo (TRUMY) Japan $26.976B 35.04
Koninklijke Philips (PHG) Netherlands $21.839B 15.32
Zimmer Biomet Holdings (ZBH) United States $18.103B 11.63
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.776B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.410B 22.31
Lantheus Holdings (LNTH) United States $5.591B 14.10
Prestige Consumer Healthcare (PBH) United States $4.170B 18.63
Perrigo (PRGO) Ireland $3.636B 9.22
Haemonetics (HAE) United States $3.462B 15.77
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.203B 26.62
ICU Medical (ICUI) United States $3.152B 23.24
GN Store Nord (GNNDY) Denmark $2.272B 18.82
LeMaitre Vascular (LMAT) United States $1.884B 42.11
QuidelOrtho (QDEL) United States $1.870B 12.86
AtriCure (ATRC) United States $1.579B 0.00
Acuren (TIC) United States $1.283B 0.00
AdaptHealth (AHCO) United States $1.120B 11.37
Neogen (NEOG) United States $1.035B 13.25
Green Thumb Industries (GTBIF) United States $1.018B 22.91
BioLife Solutions (BLFS) United States $1.015B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.853B 8.59
Kestra Medical Technologies (KMTS) United States $0.822B 0.00
CeriBell (CBLL) United States $0.668B 0.00
Evolus (EOLS) United States $0.605B 0.00
Owens & Minor (OMI) United States $0.562B 4.67
Maravai LifeSciences Holdings (MRVI) United States $0.537B 0.00
Curaleaf Holdings (CURLF) Canada $0.514B 0.00
Valneva SE (VALN) France $0.476B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Tilray Brands (TLRY) Canada $0.363B 0.00
Capricor Therapeutics (CAPR) United States $0.351B 0.00
SNDL (SNDL) Canada $0.326B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.86
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.287B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.247B 0.00
Quanterix (QTRX) United States $0.245B 0.00
ZimVie (ZIMV) United States $0.241B 10.95
OraSure Technologies (OSUR) United States $0.227B 0.00
Cresco Labs (CRLBF) United States $0.222B 0.00
Aurora Cannabis (ACB) Canada $0.220B 65.17
Biote (BTMD) United States $0.219B 6.17
Canopy Growth (CGC) Canada $0.219B 0.00
Brainsway (BWAY) Israel $0.217B 57.45
TriSalus Life Sciences (TLSI) United States $0.200B 0.00
Omeros (OMER) United States $0.187B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.52
Verano Holdings (VRNOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.175B 0.00
Organigram Global (OGI) Canada $0.171B 0.00
Exagen (XGN) United States $0.148B 0.00
Vireo Growth (VREOF) United States $0.131B 0.00
FitLife Brands (FTLF) United States $0.122B 15.02
Jin Medical (ZJYL) China $0.101B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.29
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.084B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Cytosorbents (CTSO) United States $0.079B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
TerrAscend (TSNDF) Canada $0.076B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.069B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.045B 61.29
Modular Medical (MODD) United States $0.042B 0.00
United-Guardian (UG) United States $0.038B 13.03
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.025B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00